Forte Biosciences, Inc. (FBRX) insider trading.
In Q3 2026, insiders at Forte Biosciences, Inc. reported 8 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-08-27
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Riley Antony A | Officer · CHIEF FINANCIAL OFFICER | 3 | 0 | 0 |
| Wagner Paul A. | Director, Officer · SEE REMARKS | 3 | 0 | 0 |
| Gryska David W | Director | 1 | 0 | 0 |
| Kornfeld Steven | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-27 | Gryska David W | U (D) | 5,940 | — | 0 | Form 4 |
| 2026-08-27 | Riley Antony A | U (D) | 42,600 | — | 0 | Form 4 |
| 2026-08-27 | Wagner Paul A. | U (D) | 85,482 | — | 0 | Form 4 |
| 2026-08-27 | Kornfeld Steven | U (D) | 3,960 | — | 0 | Form 4 |
| 2026-07-01 | Riley Antony A | F (D) | 134 | $21.32 | 42,600 | Form 4 |
| 2026-07-01 | Riley Antony A | M (A) | 375 | — | 42,734 | Form 4 |
| 2026-07-01 | Wagner Paul A. | M (A) | 1,250 | — | 85,580 | Form 4 |
| 2026-07-01 | Wagner Paul A. | F (D) | 98 | $21.32 | 85,482 | Form 4 |
Transaction codes in this quarter
Get FBRX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1419041&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · Forte Biosciences, Inc. on SEC.gov
Questions
Are insiders buying or selling Forte Biosciences, Inc. (FBRX)?
In Q3 2026, insiders at Forte Biosciences, Inc. reported 8 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Forte Biosciences, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/fbrx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.